S21-01 EFSA perspective: Cannabidiol (CBD) as a novel food - A. Rossi; M. Magani; I. Nuin Garciarena; O. Albert; M. Laganaro; E. Beneventi; A. Favata; A.-M. Pieger; A. Germini; G.E. Kass (Toxicology Letters, 2025)

P12-36 EFSA's updated framework of novel foods safety assessment: key aspects of toxicology and allergenicity - I. Nuin Garciarena; O. Albert; A. Favata; W. Gelbmann; M. Glymenaki; M. Laganaro; M. Magani; A. Muñoz-González; E. Noriega Fernández; A. Rossi; E. Ververis; A. Germini; et al. (Toxicology Letters, 2025)

P25-26: Data gaps in the risk assessment of Cannabidiol (CBD) as a Novel Food - A. Rossi; O. Albert; E. Kouloura; M. Laganaro; A. Muñoz González; E. Noriega Fernández; I. Nuin Garciarena; F. Rivero Pino; P. Zakidou; E. Ververis; A. Germini; G.E.N. Kass (Toxicology Letters, 2023)

P25-21: Approach and challenges in the toxicological and allergenicity risk assessment of novel proteins and their sources - I. Nuin Garciarena; O. Albert; P. Colombo; A. Fernández Dumont; M. Laganaro; A. Muñoz González; E. Noriega Fernández; G. Precup; R. Roldán Torres; A. Rossi; E. Ververis; A. Germini; et al. (Toxicology Letters, 2023)